Attention: open in a new window. E-mailPrintPDF
Shareholders of Bioton have rejected the motion for appointing an auditor, supposed to examine the sale of SciGen, the Asian subsidiary of the pharmaceutical group. The motion was filed by…

Order subscription to read this article




Order at
Order from our partners:

Call us:

Find us: